Showing results (271-280 of 356) with videos related to

Sort By:
Pageof 36
CNS Oncology|July 18, 2023
An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastomaGarni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, et al.
Neuro-Oncology|August 7, 2008
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cellsClaire Marie-Elisabeth Sauvageot, Jessica Leigh Weatherbee, Santosh Kesari, et al.
Neuro-Oncology Advances|December 23, 2024
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade gliomaCrismita Dmello, Andrew Brenner, David Piccioni, et al.
Oncotarget|October 31, 2015
Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastomaIgor F Tsigelny, Rajesh Mukthavaram, Valentina L Kouznetsova, et al.
Neuron|February 14, 2007
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant gliomaKeith L Ligon, Emmanuelle Huillard, Shwetal Mehta, et al.
JCO Precision Oncology|June 20, 2025
Molecular Correlates of Long-Term Response to Bevacizumab in GlioblastomaJohn L Villano, Catherine R Garcia, Rachael M Morgan, et al.
Scientific Reports|March 28, 2024
Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell linesValerie J Marallano, Mary E Ughetta, Rut Tejero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2015
A Novel Bioavailable BH3 Mimetic Efficiently Inhibits Colon Cancer via Cascade Effects of MitochondriaXuefeng Wang, Chen Zhang, Xiangming Yan, et al.
Scientific Reports|May 5, 2023
Activity of pemetrexed in pre-clinical chordoma models and humansSantosh Kesari, Feng Wang, Tiffany Juarez, et al.
Pageof 36